A section on the most "athletic" of the medicinal mushrooms —
cordyceps: what clinical studies measured about VO₂max,
metabolism and fatigue, and where the line of the proven
runs today.
Why cordyceps specifically
The "cordyceps–endurance" link in popular culture goes back
to the story of the Chinese women runners of the early 1990s,
whose coach attributed record results to a cordyceps
decoction; that story is closer to a myth than a study.
Scientific interest latched onto the species' compounds:
cordycepin, adenosine and polysaccharides, theoretically able
to influence energy metabolism (ATP, mitochondria) and oxygen
utilization.
Two different "cordyceps" in the studies
Behind the name in clinical work stand different products,
and that is fundamental for reading the results:
Cordyceps militaris — the cultivated
species, extracts and fruiting-body/mycelium blends; the
modern VO₂max studies in untrained and athletic populations
were done with it;
"Cordyceps sinensis" / Cs-4 — fermented
mycelium of the Paecilomyces hepiali strain, the
historical substitute for scarce wild cordyceps; the older
studies in the elderly and the Bailing nephrology
meta-analyses were done on it.
Results obtained on one product do not automatically carry
over to the other — the raw material, standardization and
doses of marker compounds differ.
The line of the proven
The site collects cordyceps work in the "physical endurance"
category — from small pilot RCTs to crossover acute
protocols. The honest summary: signals on submaximal loads
and some metabolic markers do occur, but clinical studies
have not convincingly shown a stable shift in "hard"
outcomes (VO₂max, competitive results); the designs are
small and heterogeneous. See the cards below — each one
breaks down the design and limitations of the specific
study.
A placebo-controlled double-blind parallel study: 22 healthy male long-distance runners (mean age ≈20, Juntendo University, Japan) took Cordyceps militaris mycelium extract (n=11) or placebo (n=11) for 16 weeks of preseason training. In the active group the rate of change of serum ferritin significantly exceeded placebo at weeks 4 and 8, hemoglobin and hematocrit at week 8, and creatine kinase at week 16 (p<0.05 in all cases). Baseline CK levels were above normal in both groups.
Dewi et al.'s crossover RCT (Taiwan, 2024): 14 young men took 1 g Cordyceps sinensis or placebo 2 hours before a high-intensity workout. The C. sinensis arm showed 51% faster recruitment of CD34+ progenitor cells to skeletal muscle at 3 h and a 4-fold expansion of the Pax7+ satellite-cell pool, plus reduced muscle-fiber damage markers. First data on microdosed cordyceps as a means of accelerating muscle recovery via stem-cell recruitment.
A randomized double-blind placebo-controlled study with repeated measures: 28 healthy young adults (mean age 22.7±4.1) took 4 g/day of a mushroom blend containing Cordyceps militaris or maltodextrin (placebo) for 1 week; 10 volunteers continued for 2 more weeks. After 1 week no significant changes; after 3 weeks the active group's VO2max significantly rose (+4.8 ml·kg⁻¹·min⁻¹ vs. +0.9 in placebo; p=0.042), time to exhaustion (TTE) increased by 69.8 s and ventilatory threshold by 0.7 L·min⁻¹.
Chen et al.'s pilot RCT (UCLA, 2010): 20 healthy volunteers aged 50–75 took Cs-4 (Cordyceps sinensis) 3 × 333 mg/day or placebo for 12 weeks. In the Cs-4 group the metabolic (+10.5%) and ventilatory (+8.5%) thresholds on cycle ergometry rose significantly, while VO2max did not change. Confirms the hypothesis that Cs-4 improves aerobic performance via muscle-work economization rather than maximum power.
A randomized double-blind placebo-controlled trial: 37 healthy elderly Chinese volunteers took 3 g/day of the Cs-4 fermentation product (Paecilomyces hepiali) or identical placebo capsules for 6 weeks. In the Cs-4 group peak oxygen uptake (VO₂max) rose from 1.88±0.13 to 2.00±0.14 L/min (p=0.050) and anaerobic threshold (VO₂θ) from 1.15±0.07 to 1.30±0.09 L/min (p=0.012); the placebo group did not change. The authors conclude Cs-4 benefits aerobic performance and fatigue resistance in the elderly.